
Opinion|Videos|July 29, 2024
Melanoma Research Beyond ASCO 2024: Upcoming Advances and Insights
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are the current challenges in translating clinical trial results into real-world practice for melanoma treatment? How can this process be streamlined?
- Please discuss any other data in melanoma released at ASCO 2024 that you find noteworthy to share with colleagues. (Please be prepared to discuss during the interview)
- Outside of ASCO 2024, what ongoing research efforts are you most excited for in the treatment and management of melanoma? What can we look forward to through the end of the year and beyond?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP
2
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
3
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5














































